Understanding how cells manage redox signals and their effects on health.
Decoding and Rewiring Enzymatic Redox Signal Transduction Pathways
This study is looking at how cells notice and react to important signals that help keep them healthy, with the goal of finding new ways to treat diseases like cancer and brain disorders that happen when these signals are out of balance.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project ID | NIH-11068586 on NIH RePORTER |
What this research studies
This research investigates how cells detect and respond to redox signals, which are crucial for various physiological processes. By exploring the specificity of these signaling pathways, the researchers aim to understand how to manipulate them to restore or disrupt cellular redox balance. This could lead to new strategies for treating diseases linked to redox imbalances, such as cancer and neurological disorders. The approach combines chemical biology and bioinorganic chemistry to develop innovative molecular strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from conditions related to redox imbalances, such as certain cancers or neurological disorders.
Not a fit: Patients with conditions unrelated to redox signaling or those who do not have any redox imbalance issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for diseases caused by redox imbalances, improving patient outcomes.
How similar studies have performed: While the specific approach of rewiring redox signaling pathways is novel, there have been successful studies exploring redox signaling in other contexts.
Where this research is happening
Minneapolis, United States
- University of Minnesota — Minneapolis, United States (Active)
Researchers
- Principal investigator: Bhagi, Ambika — University of Minnesota
- Study coordinator: Bhagi, Ambika
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.